Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide-Reference-Cited by-同舟云学术

Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide

Published:2024-01 Issue: Volume:199 Page:107040
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Lunati Maria Elena,Cimino Vincenzo,Bernasconi Davide,Gandolfi Alessandra,Morpurgo Paola Silvia,Tinari Camilla,Lazzaroni Elisa,Baruffaldi Laura,Muratori Milena,Montefusco Laura,Pastore Ida,Rossi Antonio,Franzetti Ivano Giuseppe,Muratori Fabrizio,Manfrini Roberto,Disoteo Olga Eugenia,Terranova Rosa,Desenzani Paolo,Girelli Angela,Ghelardi Renata,D’Addio Francesca,Ben Nasr Moufida,Berra Cesare,Folli Franco,Bucciarelli Loredana,Fiorina Paolo

Publisher

Elsevier BV

Subject

Pharmacology

Reference42 articles.

1. Pharmacological treatment of hyperglycemia in type 2 diabetes;Taylor;J. Clin. Investig.,2021

2. Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice;Lim;Nat. Rev. Endocrinol.,2023

3. Kidney and heart failure outcomes associated with SGLT2 inhibitor use;van der Aart-van der Beek;Nat. Rev. Nephrol.,2022

4. Inflammation and oxidative stress in diabetic kidney disease: the Targets for SGLT2 inhibitors and GLP-1 receptor agonists;Winiarska;Int. J. Mol. Sci.,2021

5. Primary prevention of cardiovascular and heart failure events with SGLT2 inhibitors, GLP-1 receptor agonists, and their Combination in type 2 diabetes;Wright;Diabetes Care,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer’s disease: A population-based study;Pharmacological Research;2024-08

2. Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis;Expert Review of Clinical Pharmacology;2024-06-06

3. Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics;Journal of Diabetes Investigation;2024-05-03